Mário Mariz

Statistics

Publications

Citations

104

H-Index

Active since

2009

Affiliations

Hospital Clínic de Barcelona(Current)

Clinica Universidad de Navarra

Mário Mariz is an author at Hospital Clínic de Barcelona specializing in hematologic malignancy therapy, relapsed multiple myeloma, and hematologic oncology.

Publications per year

2009–2020

Publications

Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study

Jacob P. Laubach, Fredrik Schjesvold, Mário Mariz et al. · The Lancet Oncology · 2020 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +15

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

María‐Victoria Mateos, Lucía López‐Corral, Miguel‐Teodoro Hernández et al. · Blood · 2009 · 36 citations

Medicine, Hematology, Pharmacotherapy +13

1–2 of 2